Subcutaneous Adipose Tissue Browning, Serum Orexin‑A, and Insulin Resistance Following Aerobic Exercise in High‑Fat Diet Obesity Male Wistar Rats
Abstract
Keywords
Full Text:
PDFReferences
Meldrum DR, Morris MA, Gambone JC. Obesity pandemic:
Causes, consequences, and solutions—but do we have the will?
Fertil Steril 2017;107:833‑9.
Stanford KI, Middelbeek RJ, Townsend KL, Lee MY,
Takahashi H, So K, et al. A novel role for subcutaneous adipose
tissue in exercise‑induced improvements in glucose homeostasis.
Diabetes 2015;64:2002‑14.
Inagaki T, Sakai J, Kajimura S. Transcriptional and epigenetic
control of brown and beige adipose cell fate and function. Nat
Rev Mol Cell Biol 2016;17:480‑95.
Harms M, Seale P. Brown and beige fat: Development, function
and therapeutic potential. Nat Med 2013;19:1252‑63.
Messina G, Monda V, Moscatelli F. Role of orexin system in
obesity. Biol Med 2015;07:248‑54.
Chieffi S, Carotenuto M, Monda V, Valenzano A, Villano I,
Precenzano F, et al. Orexin system: The key for a healthy life.
Front Physiol 2017;8:357‑66.
Perez‑Leighton CE, Billington CJ, Kotz CM. Orexin modulation
of adipose tissue. Biochim Biophys Acta 2014;1842:440‑5.
Ehrstrom M, Naslund E, Levin F, Kaur R, Kirchgessner AL,
Theodorsson E, et al. Pharmacokinetic profile of orexin A and
effects on plasma insulin and glucagon in the rat. Regul Pept
;119:209‑12.
Kastin AJ, Akerstrom V. Orexin A but not orexin B rapidly
enters brain from blood by simple diffusion. J Pharmacol Exp
Ther 1999;289:219‑23.
Zink AN, Bunney PE, Holm AA, Billington CJ, Kotz CM.
Neuromodulation of orexin neurons reduces diet‑induced
adiposity. Int J Obes (Lond) 2018;42:737‑45.
Gollisch KS, Brandauer J, Jessen N, Toyoda T, Nayer A,
Hirshman MF, et al. Effects of exercise training on subcutaneous
and visceral adipose tissue in normal‑and high‑fat diet‑fed rats.
Am J Physiol Endocrinol Metab 2009;297:E495‑504.
Novelli E, Diniz Y, Galhardi C, Ebaid G, Rodrigues H, Mani F,
et al. Anthropometrical parameters and markers of obesity in
rats. Lab Anim 2007;41:111‑9.
Caponi PW, Lehnen AM, Pinto GH, Borges J, Markoski M,
Machado UF, et al. Aerobic exercise training induces metabolic
benefits in rats with metabolic syndrome independent of dietary
changes. Clinics 2013;68:1010‑7.
Antunes LC, Elkfury JL, Jornada MN, Foletto KC, Bertoluci MC.
Validation of HOMA‑IR in a model of insulin‑resistance induced
by a high‑fat diet in Wistar rats. Arch Endocrinol Metab
;60:138‑42.
Cao H. Adipocytokines in obesity and metabolic disease.
J Endocrinol 2014;220:T47‑59.
Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest
;106:473‑81.
Ickin Gulen M, Guven Bagla A, Yavuz O, Hismiogullari A.
Histopathological changes in rat pancreas and skeletal muscle
associated with high fat diet induced insulin resistance. Biotech
Histochem 2015;90:495‑505.
Suk M, Shin Y. Effect of high‑intensity exercise and high‑fat
diet on lipid metabolism in the liver of rats. J Exerc Nutrition
Biochem 2015;19:289‑95.
Yamamoto Y, Ueta Y, Date Y, Nakazato M, Hara Y, Serino R,
et al. Down regulation of the prepro‑orexin gene expression in
genetically obese mice. Brain Res Mol Brain Res 1999;65:14‑22.
Tsuneki H, Murata S, Anzawa Y, Soeda Y, Tokai E, Wada T, et al.
Age‑related insulin resistance in hypothalamus and peripheral
tissues of orexin knockout mice. Diabetologia 2008;51:657‑67.
Flores Á, Maldonado R, Berrendero F. Cannabinoid‑hypocretin
cross‑talk in the central nervous system: What we know so far.
Front Neurosci 2013;7:1‑17.
Chieffi S, Messina G, Villano I, Messina A, Esposito M,
Monda V, et al. Exercise influence on hippocampal function:
Possible involvement of orexin‑A. Front Physiol 2017;8:1‑8.
Messina G, Di Bernardo G, Viggiano A, De Luca V, Monda V,
Messina A, et al. Exercise increases the level of plasma orexin A
in humans. J Basic Clin Physiol Pharmacol 2016;27:611‑6.
Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA,
Wu MF, John J, et al. Release of hypocretin (orexin) during
waking and sleep states. J Neurosci 2002;22:5282‑6.
Ferrante C, Orlando G, Recinella L, Leone S, Chiavaroli A,
Di Nisio C, et al. Central inhibitory effects on feeding induced
by the adipo‑myokine irisin. Eur J Pharmacol 2016;791:389‑94.
Hao YY, Yuan HW, Fang PH, Zhang Y, Liao YX, Shen C, et al.
Plasma orexin‑A level associated with physical activity in obese
people. Eat Weight Disord 2016;19:69‑77.
Williams RH, Jensen LT, Verkhratsky A, Fugger L, Burdakov D.
Control of hypothalamic orexin neurons by acid and CO2
. Proc
Natl Acad Sci U S A. 2007;104:10685‑90.
Alizadeh A A, Rahmani-Nia F, Mohebbi H, Zakerkish M. Acute
aerobic exercise and plasma levels of orexin A, insulin, glucose,
and insulin resistance in males with type 2 diabetes. Jundishapur
J Health Sci 2016;8:15-19.
Park JH, Shim HM, Na AY, Bae JH, Im SS, Song DK. Orexin
A regulates plasma insulin and leptin levels in a time‑dependent
manner following a glucose load in mice. Diabetologia
;58:1542‑50.
Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A,
Stadheim HK, et al. The effects of acute and chronic exercise on
PGC-1α, irisin and browning of subcutaneous adipose tissue in
humans. FEBS J 2014;281:739‑49.
Russell S, Small C, Sunter D, Morgan I, Dakin C, Cohen M,
et al. Chronic intraparaventricular nuclear administration of
orexin A in male rats does not alter thyroid axis or uncoupling
protein‑1 in brown adipose tissue. Regul Pept 2002;104:61‑8.
Oliveira BA, Pinhel MA, Nicoletti CF, Oliveira CC,
Quinhoneiro DC, Noronha NY, et al. UCP1 and UCP3
expression is associated with lipid and carbohydrate oxidation
and body composition. PLoS One 2016;11:e0150811.
Shen Y, Zhao Y, Zheng D, Chang X, Ju S, Guo L. Effects of
orexin A on GLUT4 expression and lipid content via MAPK
signaling in 3T3‑L1 adipocytes. J Steroid Biochem Mol Biol
;138:376‑83.
Farrell PA, Joyner M, Caiozzo V. ACSM’s advanced exercise
physiology: Wolters Kluwer Health Adis (ESP); 2011.